Today's Top Gainer
| SYMBOL | CMP | Chg (%) |
|---|---|---|
Note:Top Gainer - Nifty 50 More
Natco Pharma Ltd - Share Price
NATCOPHARM
Financials
News & Updates
Natco Pharma completes investments in OMRV Hospitals
Dec 04,2019 08:39 AM
The company will be holding 12.81% of the share on a fully diluted basis of the share capital of OMRV Hospitals, the company said.
Natco Pharma completes investments in OMRV Hospitals Dec 03,2019
Natco Pharma's Vizag facility begins operations Nov 15,2019
Natco Pharma fixes record date for 2nd interim dividend Nov 14,2019
Natco Pharma posts PAT decline of 35% in Q2, stock down 3% Nov 13,2019
Board of Natco Pharma recommends Second Interim Dividend Nov 13,2019
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Summary & Reports
No Company Summary found
Registered Office
Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033
Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in
Registrar Office
12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA
Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com
Reports by natco-pharma-ltd
Latest Release by natco-pharma-ltd
Result Express
Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates
Dec 13, 2019 07:38 AM
The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.
Shareholding Snapshot
Loading ...
| Sep - 2019 | |
|---|---|
| Promoter | - |
| Foreign | 1.34% |
| Indian | 47.64% |
| Total Promoter | 48.98% |
| Non Promoter | - |
| Institutions | 30.56% |
| Non-Institutions | 20.47% |
| Total Non-Promoter | 51.02% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Dividend
Annc. Date
12 Nov 2019
Effective. Date
21 Nov 2019
Divi. Type
Interim 2
Divi.(%)
50
Divi. Amt.
1
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More
Purpose
Board Meeting
Exp. Date
12 Nov 2019
Annc. Date
04 Nov 2019
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More
Purpose
AGM
Exp. Date
05 Sep 2019
Annc. Date
09 Aug 2019
AGM 05/09/201936th Annual Report for the year 2018-19Book Closure from 3rd September 2019 to 5th Sep... More
